These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Brunner P; Sözer-Topcular N; Jockers R; Ravid R; Angeloni D; Fraschini F; Eckert A; Müller-Spahn F; Savaskan E Eur J Histochem; 2006; 50(4):311-6. PubMed ID: 17213040 [TBL] [Abstract][Full Text] [Related]
7. MT(1) melatonin receptor in the human retina: expression and localization. Scher J; Wankiewicz E; Brown GM; Fujieda H Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):889-97. PubMed ID: 11867612 [TBL] [Abstract][Full Text] [Related]
8. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain. Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605 [TBL] [Abstract][Full Text] [Related]
9. The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors. Pappolla MA; Simovich MJ; Bryant-Thomas T; Chyan YJ; Poeggeler B; Dubocovich M; Bick R; Perry G; Cruz-Sanchez F; Smith MA J Pineal Res; 2002 Apr; 32(3):135-42. PubMed ID: 12074096 [TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease. Mizukami K; Ishikawa M; Akatsu H; Abrahamson EE; Ikonomovic MD; Asada T Neuropathology; 2011 Oct; 31(5):503-9. PubMed ID: 21269332 [TBL] [Abstract][Full Text] [Related]
11. Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients. Adams SL; Benayoun L; Tilton K; Chavez OR; Himali JJ; Blusztajn JK; Seshadri S; Delalle I J Alzheimers Dis; 2017; 60(1):43-56. PubMed ID: 28777754 [TBL] [Abstract][Full Text] [Related]
12. Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease-like pathology. Stefanova NA; Maksimova KY; Kiseleva E; Rudnitskaya EA; Muraleva NA; Kolosova NG J Pineal Res; 2015 Sep; 59(2):163-77. PubMed ID: 25988948 [TBL] [Abstract][Full Text] [Related]
13. Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study. Shiozaki K; Iseki E; Hino H; Kosaka K J Neurol Sci; 2001 Dec; 193(1):23-8. PubMed ID: 11718746 [TBL] [Abstract][Full Text] [Related]
16. Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats. Ananth C; Gopalakrishnakone P; Kaur C Hippocampus; 2003; 13(3):375-87. PubMed ID: 12722978 [TBL] [Abstract][Full Text] [Related]
17. Melatonin receptors in rat hippocampus: molecular and functional investigations. Musshoff U; Riewenherm D; Berger E; Fauteck JD; Speckmann EJ Hippocampus; 2002; 12(2):165-73. PubMed ID: 12000116 [TBL] [Abstract][Full Text] [Related]
18. Melatonin in Synaptic Impairments of Alzheimer's Disease. Shi Y; Fang YY; Wei YP; Jiang Q; Zeng P; Tang N; Lu Y; Tian Q J Alzheimers Dis; 2018; 63(3):911-926. PubMed ID: 29710712 [TBL] [Abstract][Full Text] [Related]
19. Factors regulating the influence of melatonin on hippocampal evoked potentials: comparative studies on different strains of mice. El-Sherif Y; Hogan MV; Tesoriero J; Wieraszko A Brain Res; 2002 Aug; 945(2):191-201. PubMed ID: 12126881 [TBL] [Abstract][Full Text] [Related]
20. Melatonin decreases cell proliferation and transformation in a melatonin receptor-dependent manner. Jones MP; Melan MA; Witt-Enderby PA Cancer Lett; 2000 Apr; 151(2):133-43. PubMed ID: 10738107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]